Antibiotic research at Harvard lab threatened by federal funding cuts

DBMI's Michael Baym is interviewed about the loss of five federal grants to his lab this week.

Stephanie Brown and Lynn Jolicoeur | WBUR
WBUR All Things Considered logo

Researchers at Harvard are adjusting to a devastating reality this week: The Trump administration has announced it's cutting more than $2 billion in funding to the institution.

Michael Baym is a microbiologist and professor at Harvard Medical School who studies antibiotic resistance. This week he lost five federal grants to his lab. 

Baym joined WBUR's All Things Considered to talk about the impact of the cuts. Listen below or find the interview on the WBUR website.

Also see

Feds yank funds from Harvard breast cancer, fertility, antibiotics research | WBUR

Research at Risk: Preventing Antibiotic Resistance